Nathan Dahl, MD

Publications

• Walker FM, Sobral LM, Danis E, Sanford B, Donthula S, Balakrishnan I, Wang D, Pierce A, Karam SD, Kargar S, Serkova NJ, Foreman NK, Venkataraman S, Dowell R, Vibhakar R, Dahl NA. Rapid P-TEFb-dependent transcriptional reorganization underpins the glioma adaptive response to radiotherapy. Nat Commun. 2024 May 30;15(1):4616. PubMed PMID: 38816355
• Kalter JA, Yang RA, Toland A, Milla S, Lund TC, Hankinson T, Dahl NA. IDH-mutant astrocytoma arising from a demyelinating plaque in a child with X-linked adrenoleukodystrophy. J Neuropathol Exp Neurol. 2024 Mar 20;83(4):289-292. PubMed PMID: 38456320
• Chan PP, Sabus A, Hemenway MS, Chatfield KC, White CJ, Mirsky DM, Foreman NK, Dahl NA. Thromboembolic toxicity observed with concurrent trametinib and lenalidomide therapy. Pediatr Blood Cancer. 2023 Mar;70(3):e30190. PubMed PMID: 36602034
• Walker FM, Sobral LM, Danis E, Sanford B, Balakrishnan I, Wang D, Pierce A, Karam SD, Serkova NJ, Foreman NK, Venkataraman S, Dowell R, Vibhakar R, Dahl NA. Rapid PTEFb-dependent transcriptional reorganization underpins the glioma adaptive response to radiotherapy. bioRxiv. 2023 Jan 25. PubMed PMID: 36747867
• Norris GA, Willard N, Donson AM, Gaskell A, Milgrom SA, O'Neill BR, Nijmeh H, Haag M, Gilani A, Foreman NK, Dahl NA. PDGFB:APOBEC3C fusion in congenital diffuse high-grade glioma of the brainstem. J Neuropathol Exp Neurol. 2023 Jan 20;82(2):183-186. PubMed PMID: 36440550
• Milgrom SA, Koo J, Foreman N, Liu AK, Campbell K, Dorris K, Green AL, Dahl NA, Donson AM, Vibhakar R, Mulcahy Levy JM. Peri-transplant radiation therapy for young children treated with high-dose chemotherapy for primary brain tumors. Adv Rad Oncol (2022). Jul 7(4).
• Madhavan K, Balakrishnan I, Chetty SL, Pierce A, Sanford B, Fosmire S, Elajaili H, Walker F, Wang D, Nozik-Grayck E, Mitra S, Dahl NA, Vibhakar R, Venkataraman S. Venetoclax cooperates with ionizing radiation to attenuate Diffuse Midline Glioma tumor growth. Clin Cancer Res (2022). Jun 1;28(11):2409-2424.
• Dahl NA, Vibhakar R. Converging evidence for inhibition of transcriptional control in high-grade gliomas. Neuro-Oncology (2021). Aug 2;23(8):1225-1227.
• Dahl NA, Donson AM, Sanford B, Wang D, Walker FM, Gilani A, Foreman NK, Tinkle CL, Baker SJ, Hoffman LM, Venkataraman SV, Vibhakar R. NTRK fusions can co-occur with H3K27M mutations and may define druggable subclones within diffuse midline gliomas. J Neuropathol Exp Neurol (2021). 80(4): 345–353.
• Dahl NA, Vibhakar R. Converging evidence for inhibition of transcriptional control in high-grade gliomas. Neuro Oncol. 2021 Aug 2;23(8):1225-1227. PubMed PMID: 33984150
• Veo B, Danis E, Pierce A, Wang D, Fosmire S, Sullivan KD, Joshi M, Khanal S, Dahl N, Karam S, Serkova N, Venkataraman S, Vibhakar R. Transcriptional control of DNA repair networks by CDK7 regulates sensitivity to radiation in MYC-driven medulloblastoma. Cell Rep. 2021 Apr 27;35(4):109013. PubMed PMID: 33910002
• Dahl NA, Donson AM, Sanford B, Wang D, Walker FM, Gilani A, Foreman NK, Tinkle CL, Baker SJ, Hoffman LM, Venkataraman S, Vibhakar R. NTRK Fusions Can Co-Occur With H3K27M Mutations and May Define Druggable Subclones Within Diffuse Midline Gliomas. J Neuropathol Exp Neurol. 2021 Mar 22;80(4):345-353. PubMed PMID: 33749791
• Balakrishnan I, Danis E, Pierce A, Madhavan K, Wang D, Dahl N, Sanford B, Birks DK, Davidson N, Metselaar DS, Meel MH, Lemma R, Donson A, Vijmasi T, Katagi H, Sola I, Fosmire S, Alimova I, Steiner J, Gilani A, Hulleman E, Serkova NJ, Hashizume R, Hawkins C, Carcaboso AM, Gupta N, Monje M, Jabado N, Jones K, Foreman N, Green A, Vibhakar R, Venkataraman S. Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG. Cell Rep. 2020 Oct 20;33(3):108286. PubMed PMID: 33086074
• Dahl NA. Sacramentality in Palliation. J Clin Oncol. 2020 Aug 10;38(23):2695-2696. PubMed PMID: 32463738
• Dahl NA, Danis E, Balakrishnan I, Wang D, Pierce A, Walker FM, Gilani A, Serkova NJ, Madhavan K, Fosmire S, Green AL, Foreman NK, Venkataraman S, Vibhakar R. Super Elongation Complex as a Targetable Dependency in Diffuse Midline Glioma. Cell Rep. 2020 Apr 7;31(1):107485. PubMed PMID: 32268092
• Balakrishnan I, Danis E, Pierce A, Madhavan K, Wang D, Dahl N, Sanford B, Birks DK, Davidson N, Metselaar DS, Meel MH, Lemma R, Donson A, Vijmasi T, Katagi H, Sola I, Fosmire S, Alimova I, Steiner J, Gilani A, Hulleman E, Serkova NJ, Hashizume R, Hawkins C, Carcaboso AM, Gupta N, Monje M, Jabado N, Jones K, Foreman N, Green A, Vibhakar R, Venkataraman S. Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG. Cell Rep. 2020 Oct 20;33(3):108286. PubMed PMID: 33086074
• Dahl NA. Sacramentality in Palliation. J Clin Oncol. 2020 Aug 10;38(23):2695-2696. PubMed PMID: 32463738
• Green A, Flannery PC, Hankinson TC, O’Neill B, Amani V, DeSisto J, Knox A, Lemma R, Hoffman L, Mulcahy Levy J, Raybin J, Hemenway M, Gilani A, Koschmann C, Dahl NA, Handler M, Pierce A, Venkataraman S, Foreman N, Vibhakar R, Wempe M, Dorris K. Preclinical and clinical investigation of intratumoral chemotherapy pharmacokinetics in DIPG. Neuro-Oncology Advances (2020) Volume 2, Issue 1, January-December 2020.
• Veo B, Danis E, Pierce A, Wang D, Fosmire S, Sullivan K, Joshi M, Khanal S, Dahl NA, Karam S, Serkova N, Venkataraman S, Vibhakar R. Transcriptional control of DNA repair networks by CDK7 regulates sensitivity to radiation in Myc-driven medulloblastoma.

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234

Specialty Information

Specialties

• Pediatric Hematology / Oncology, Board Certification